Dietary components modify the ability of garlic to suppress 7,12-dimethylbenz(a)anthracene-induced mammary DNA

H Amagase1, E M Schaffer, J A Milner

  • 1Department of Nutrition, The Pennsylvania State University, University Park 16802, USA.

Insights

Dietary garlic reduces mammary cell DNA adducts caused by 7,12-dimethylbenz(a)anthracene (DMBA) in rats. This protective effect is influenced by dietary casein, L-methionine, and corn oil levels.

Area of Science:

  • Nutritional biochemistry
  • Cancer prevention research
  • Toxicology

Background:

  • 7,12-dimethylbenz(a)anthracene (DMBA) is a potent carcinogen that induces DNA adducts in mammary cells.
  • Dietary factors can modulate the formation of DMBA-induced DNA adducts.
  • Garlic is known for its potential chemopreventive properties.

Purpose of the Study:

  • To investigate the influence of various dietary components on garlic's efficacy in reducing DMBA-induced mammary cell DNA adducts in rats.
  • To determine how dietary casein, L-methionine, and corn oil levels interact with garlic supplementation to affect DNA adduct formation.

Main Methods:

  • Rats were fed diets with or without garlic powder for 2 weeks before DMBA treatment.
  • Diets varied in casein (12 or 36 g/100 g), L-methionine (0.3 or 0.9 g/100 g), and corn oil (5 or 20 g/100 g) content.
  • Mammary cell DNA adduct levels were quantified following DMBA administration.

Main Results:

  • Garlic supplementation significantly reduced DMBA-induced DNA adducts.
  • Higher casein and L-methionine levels decreased adducts, and garlic's effect was more pronounced with lower methionine.
  • Increased corn oil intake elevated adducts, an effect mitigated by garlic.
  • Combined garlic, selenite, and retinyl acetate showed greater inhibition than individual supplements.

Conclusions:

  • Dietary garlic demonstrates chemopreventive potential against DMBA-induced mammary DNA adducts in rats.
  • The protective effect of garlic is significantly modulated by the levels of dietary casein, L-methionine, and corn oil.
  • Optimizing dietary composition alongside garlic intake may enhance its cancer-preventive benefits.

Related Concept Videos

The Scientific Method01:32

The Scientific Method

The scientific method is a detailed, empirical problem-solving process used by biologists and other scientists. This iterative approach involves formulating a question based on observation, developing a testable potential explanation for the observation (called a hypothesis), making and testing predictions based on the hypothesis, and using the findings to create new hypotheses and predictions.Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...